全文获取类型
收费全文 | 1602篇 |
免费 | 101篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 106篇 |
妇产科学 | 55篇 |
基础医学 | 132篇 |
口腔科学 | 14篇 |
临床医学 | 187篇 |
内科学 | 319篇 |
皮肤病学 | 32篇 |
神经病学 | 157篇 |
特种医学 | 71篇 |
外科学 | 315篇 |
综合类 | 22篇 |
预防医学 | 168篇 |
眼科学 | 13篇 |
药学 | 64篇 |
中国医学 | 1篇 |
肿瘤学 | 57篇 |
出版年
2023年 | 11篇 |
2021年 | 14篇 |
2020年 | 16篇 |
2019年 | 22篇 |
2018年 | 22篇 |
2017年 | 20篇 |
2016年 | 16篇 |
2015年 | 27篇 |
2014年 | 33篇 |
2013年 | 44篇 |
2012年 | 59篇 |
2011年 | 47篇 |
2010年 | 39篇 |
2009年 | 40篇 |
2008年 | 57篇 |
2007年 | 77篇 |
2006年 | 62篇 |
2005年 | 67篇 |
2004年 | 64篇 |
2003年 | 74篇 |
2002年 | 62篇 |
2001年 | 36篇 |
2000年 | 40篇 |
1999年 | 31篇 |
1998年 | 33篇 |
1997年 | 30篇 |
1996年 | 33篇 |
1995年 | 29篇 |
1994年 | 25篇 |
1993年 | 19篇 |
1992年 | 38篇 |
1991年 | 44篇 |
1990年 | 38篇 |
1989年 | 44篇 |
1988年 | 35篇 |
1987年 | 24篇 |
1986年 | 20篇 |
1985年 | 26篇 |
1984年 | 21篇 |
1983年 | 20篇 |
1982年 | 12篇 |
1981年 | 14篇 |
1980年 | 12篇 |
1979年 | 15篇 |
1978年 | 15篇 |
1977年 | 20篇 |
1976年 | 8篇 |
1974年 | 8篇 |
1936年 | 8篇 |
1922年 | 8篇 |
排序方式: 共有1724条查询结果,搜索用时 46 毫秒
141.
142.
The acquired immunodeficiency syndrome and transplantation 总被引:1,自引:0,他引:1
143.
144.
ANNA-MARIA WNUK-WOJNAR LESZEK GIEC JANUSZ DRZEWIECKI MARIA TRUSZ-GLUZA RZEJ DABROWSKI STANISAW PASYK 《Pacing and clinical electrophysiology : PACE》1990,13(12):2127-2132
WNUK-WOJNAR, A.M., ET AL.: Predictors of Ventricular Tachycardia Inducibility in Programmed Electrical Stimulation and Effectiveness of Serial Drug Testing: Polish Multicenter Study. In 100 patients with IHD and complex ventricular arrhythmias, programmed electrical stimulation was performed using up to three extrastimuli at sinus rhythm, and paced 100, 120, and 140 beats/min delivered from the RV apex, outflow tract or the LV with ventricular mapping to evaluate late potentials (LP) in 41 patients. Sustained monomorphic VT (SMVT) was provoked in 91% of 42 patients with a history of VT/VF, p < 0.001, all five patients had SMVT in 24-hour ECG, p < 0.005, and 91% of 21 patients with LV dyskinesis, p < 0.01. After depolarizations were found in 62% of 21 patients with a history of VT, in 58% of 31 patients with inducible VT, p < 0.01 and in five of six patients with LV dyskinesis. In patients with inducible VT, LP had a higher amplitude (105 ± 35 vs 60 ± 47 µV) and were more delayed (202 ± 96 vs 133 ± 75 msec) than in noninducible patients. In 17 patients, serial drug testing was performed after oral administration using mexilitene, disopyramide, chinidine, propafenone, sotalol, and amiodarone. If one drug was tested, the therapy efficacy was 25% if two drugs-60%, and if three drugs-75%. In eight patients, VT was inducible in all tests, but in only one of these patients chronic antiarrhythmic therapy was not effective. We conclude that the most important predictors of VT inducibility are a history of VT or 24-hour ECG, and LV dyskinesis. Serial drug testing is efficient only when many drugs are tested, but even if VT is inducible, it does not exclude the possibility of a good clinical outcome in chronic therapy. 相似文献
145.
Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxic pulmonary hypertension 总被引:5,自引:0,他引:5
OBJECTIVE: To determine whether the combination of the phosphodiesterase 5 inhibitor zaprinast and inhaled nitric oxide (NO) decreases hypoxic pulmonary hypertension in the rat. DESIGN: Prospective, experimental study. SETTING: Animal laboratory of a university medical center. SUBJECTS: Male Sprague-Dawley rats. INTERVENTIONS: Anesthetized rats were mechanically ventilated and instrumented for measurement of mean systemic arterial pressure, pulmonary arterial pressure, and cardiac output. In group 1, four acute hypoxic challenges (FIO2 = 0.17 for 5 mins) were performed: initial, during 40 ppm inhaled NO, immediately after discontinuation of 5 mins of inhaled NO, and final. In group 2 rats, an initial hypoxic challenge was performed and rats then received zaprinast (3 mg/kg bolus followed by 0.3 mg/kg/min infusion). Four hypoxic challenges analogous to group 1 were then performed during zaprinast administration. MEASUREMENTS AND MAIN RESULTS: Initial hypoxic challenge produced similar increases in pulmonary arterial pressure in both groups. In group 1, inhaled NO either only before or only during hypoxia decreased the pulmonary hypertensive response to hypoxia. In group 2, zaprinast administration did not alter hemodynamics. Zaprinast alone decreased the pulmonary hypertensive response to hypoxia. The combination of zaprinast and inhaled NO (either before or during hypoxia) abolished the pulmonary hypertensive response to hypoxia. CONCLUSIONS: Treatment with inhaled NO for 5 mins before but not during hypoxia is as effective as inhaled NO during hypoxia. Inhaled NO and zaprinast both decrease the pulmonary hypertensive response to hypoxia, and the combination abolishes the response. The combination of a phosphodiesterase 5 inhibitor and inhaled NO may have clinical applicability in the treatment of pulmonary hypertension. 相似文献
146.
Recent advances in advanced renal cell cancer (RCC) research have produced new drugs and therapies for patients with metastatic disease leading to higher response rates, improvements in progression-free survival, and longer overall survival. These advances have yet to be realized in patients with early-stage kidney cancer, and to date, no drug has been approved for the adjuvant treatment of localized kidney cancer. The current standard of care for localized high-risk kidney cancers is resection of the primary tumor. Here, we review the results of recently completed adjuvant vascular endothelial growth factor receptor 2 (VEGFR2) tyrosine kinase inhibitor (TKI) trials in RCC that have been reported, or are awaiting results. Further, we discuss the new immune checkpoint inhibitor adjuvant trials planned. There is hope that these trials may lead to new options and longer survival for patients with localized high-risk kidney cancer. 相似文献
147.
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. 总被引:10,自引:0,他引:10 下载免费PDF全文
C P Genain M H Nguyen N L Letvin R Pearl R L Davis M Adelman M B Lees C Linington S L Hauser 《The Journal of clinical investigation》1995,96(6):2966-2974
In the human disease multiple sclerosis (MS), the immune mechanisms responsible for selective destruction of central nervous system myelin are unknown. In the common marmoset Callithrix jacchus, a unique demyelinating form of experimental allergic encephalomyelitis resembling MS can be induced by immunization with whole myelin. Here we show that the MS-like lesion can be reproduced by immunization against the extracellular domain of a single myelin protein, myelin/oligodendrocyte glycoprotein (MOG). By contrast, immunization against the quantitatively major myelin proteins myelin basic protein or proteolipid protein results in inflammation but little or no demyelination. Furthermore, in the presence of encephalitogenic (e.g., disease-inducing) T cells, the fully demyelinated lesion is reconstructed by systemic administration of IgG purified from whole myelin-, or MOG-immunized animals, and equally by a monoclonal antibody against MOG, but not by control IgG. Encephalitogenic T cells may contribute to the MS-like lesion through disruption of the blood-brain barrier that permits access of demyelinating antibody into the nervous system. The identification of MOG as a major target antigen for autoimmune demyelination in a nonhuman primate should facilitate development of specific immunotherapies for human MS. 相似文献
148.
HE Connor W Feniuk DT Beattie PC North AW Oxford DA Saynor PPA Humphrey 《Cephalalgia : an international journal of headache》1997,17(3):145-152
The biological profile of naratriptan (N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethane-sulphona-mide), a novel 5HT1B/1D receptor agonist, was investigated in a variety of experimental models of relevance to migraine. Naratriptan has high affinity for human recombinant 5HT1B and 5HT1D receptors (pKi = 8.70.03 and 8.30.1, respectively) and causes contractions of dog isolated basilar and middle cerebral artery (EC50 values of 0.11 and 0.07 M, respectively). Naratriptan causes small contractions of human isolated coronary arteries (EC50 value of 0.17 M; maximum contraction equivalent to 33% of 5HT maximum). In anaesthetized dogs, naratriptan causes selective vasoconstriction of the carotid arterial bed (CD50 dose = 193 g kg−1 ) and, in anaesthetized rats, naratriptan selectively inhibits neurogenic plasma protein extravasation in the dura (ID50 = 4.1 g kg−1 ). In a variety of antinociceptive tests, naratriptan has no effect even at high doses. In conscious rats and dogs, naratriptan has high oral bioavailability (71% and 95%, respectively). The data show that naratriptan is a selective agonist at 5HT1B/1D receptors, with a pharmacological profile very similar to that of sumatriptan, albeit 2-3 fold more potent. These observations, coupled with high oral bioavailability in animals, suggest that naratriptan has the profile of an orally effective anti-migraine drug. 相似文献
149.
Gwendolyn M. Stritter MD Ronald G. Pearl MD Dr Frederick G. Mihm MD 《Journal of clinical monitoring and computing》1988,4(3):204-209
A clinical study was performed in two phases to determine whether pulmonary artery oximeter catheters that were impregnated or bonded with heparin would affect the accuracy of measurements of in vivo mixed venous oxygen saturation (S
O2). In phase 1, 40 patients were catheterized with either a heparin-impregnated or a plain pulmonary artery catheter. Blood was sampled at random times to correlate in vivo with in vitro S
O2 measurements. In phase 2, 16 patients who were not receiving systemic heparin therapy or aspirin and who had no coagulopathies were catheterized with either a heparin-bonded or a plain pulmonary artery catheter in a blinded order. In phase 1, a total of 364 blood samples were obtained from 40 patients. Linear regression analysis of the pooled data demonstrated y=0.98x–0.01,r=0.93,P<0.001, andn=141 with heparin-impregnated catheters; and y=0.87x+8.0,r=0.81,P<0.001, andn=223 with plain catheters. The mean difference (in vivo minus in vitro) revealed a similar error (–1.3±0.4 versus –1.4±0.4, respectively, mean±SE). The 95% confidence limits of an individual value (±8.1 versus ±12.3) suggested slightly greater accuracy with heparin-impregnated catheters. In phase 2, a total of 134 blood samples were obtained from 16 patients. Linear regression analysis showed nearly equal performance with heparin-bonded and plain catheters (r=0.97 versusr=0.98, respectively) with similar slopes (1.0 versus 1.1, respectively) but different intercepts (–0.6 versus –8.4, respectively). Analysis of the mean difference revealed a measurement error of 0.4±0.3 versus –1.3±0.3 with similar 95% confidence limits of individual values (±5.0 versus ±4.8, respectively). These differences do not appear clinically important. These data suggest that heparinization only minimally enhanced accuracy with a pulmonary artery oximetry system, which accurately measured S
O2 to within 3 to 4% of true values. 相似文献
150.